Quetiapine fumarate
Quetiapine Fumarate is a generic atypical antipsychotic medication used to treat schizophrenia, bipolar disorder, and major depressive disorder. It comes as oral tablets in strengths of 25mg, 50mg, 100mg, 200mg, 300mg, and 400mg. Manufactured by XLCare Pharmaceuticals Inc. and Camber Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Quetiapine Fumarate is a generic atypical antipsychotic medication used to treat schizophrenia, bipolar disorder, and major depressive disorder. It comes as oral tablets in strengths of 25mg, 50mg, 100mg, 200mg, 300mg, and 400mg. Manufactured by XLCare Pharmaceuticals Inc. and Camber Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Quetiapine fumarate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Quetiapine fumarate — ANDA 206252 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206252"
}
]
|
| identifier | ANDA206252 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-safety",
"health-care",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Quetiapine fumarate |
